ShedRx vs Better MedSpa
Two GLP-1 desks, one scoreboard. We put ShedRx and Better MedSpa head-to-head on the published Brief Score — the same six factors, scored the same way.
The verdict
ShedRx takes this head-to-head.
ShedRx scores 87 to 52 on our six-factor Brief Score — A weight-focused program with a low tracked tirzepatide rate and an oral/sublingual route for the needle-averse.
That doesn't make Better MedSpa a bad call — it's best for readers who want illinois residents wanting physician-led glp-1 weight loss with in-person or telehealth options. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| ShedRx | Better MedSpa | |
|---|---|---|
| Brief Score | 87/100 (B+) | 52/100 (C) |
| Semaglutide | $199/mo | Not disclosed |
| Tirzepatide | $299/mo | Not disclosed |
| Coverage | Not disclosed | 1 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
| On the tracker | Fallingprice falling | Newnew to the tracker, no prior reading |
ShedRx: Competitive tirzepatide rate trimmed further this cycle — cheapest tirz among our partner desks.
Better MedSpa: New to the tracker on 1 August 2026. This program publishes no monthly medication price, so there is no line for us to track until it does.
● Not sold on either?
CoreAge Rx tops the whole board at 94/100.
The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.